To evaluate whether assigning higher ASA-PS classifications based solely on a BMI ≥ 40 kg/m2 accurately reflects peri-operative risk for patients undergoing metabolic surgery, specifically in terms of their metabolic health status.
Key Findings:
Higher ASA-PS scores were often assigned to patients with obesity prior to the 2014 update, potentially on subjective grounds.
Obesity-related complications are significant for metabolic surgery indications, but BMI alone does not accurately predict peri-operative risks.
Patients with metabolically healthy obesity may not exhibit the same peri-operative risks as those with metabolically unhealthy obesity, indicating a need for nuanced risk assessment.
Interpretation:
The study suggests that the ASA-PS classification based solely on BMI ≥ 40 kg/m2 may not effectively stratify peri-operative risk, as it does not account for the metabolic health status of patients, which is crucial for accurate risk assessment.
Limitations:
Lack of differentiation between patients with and without chronic cardiac or metabolic diseases limits the applicability of findings.
Absence of investigation into the specific impact of BMI ≥ 40 kg/m2 on peri-operative complications restricts understanding of its role in risk stratification.
Conclusion:
The findings indicate that ASA-PS III classification based solely on BMI ≥ 40 kg/m2 may not contribute meaningfully to peri-operative risk stratification in metabolic surgery, highlighting the need for a more comprehensive assessment approach.
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.